Extracellular Signal-Regulated MAP Kinases
"Extracellular Signal-Regulated MAP Kinases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS.
| Descriptor ID |
D048049
|
| MeSH Number(s) |
D08.811.913.696.620.682.700.567.249 D12.644.360.450.169 D12.776.476.450.169
|
| Concept/Terms |
Extracellular Signal-Regulated MAP Kinases- Extracellular Signal-Regulated MAP Kinases
- Extracellular Signal Regulated MAP Kinases
- MAP Kinases, Extracellular Signal-Regulated
- MAP Kinases, Extracellular Signal Regulated
- ERK MAP Kinases
- Extracellular Signal-Regulated Kinases
- Extracellular Signal Regulated Kinases
- Kinases, Extracellular Signal-Regulated
|
Below are MeSH descriptors whose meaning is more general than "Extracellular Signal-Regulated MAP Kinases".
Below are MeSH descriptors whose meaning is more specific than "Extracellular Signal-Regulated MAP Kinases".
This graph shows the total number of publications written about "Extracellular Signal-Regulated MAP Kinases" by people in this website by year, and whether "Extracellular Signal-Regulated MAP Kinases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Extracellular Signal-Regulated MAP Kinases" by people in Profiles.
-
miR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene. PLoS One. 2012; 7(1):e30772.
-
Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference. Drug Alcohol Depend. 2009 Jan 01; 99(1-3):231-9.
-
Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 05; 147B(7):1253-7.
-
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr. 2008 Aug; 29(4):293-302.